BP650

Terfenadine

British Pharmacopoeia (BP) Reference Standard

• Sinónimos: α-[4-(1,1-Dimethylethyl)phenyl]-4-(hydroxydiphenylmethyl)-1-piperidinebutanol
• Fórmula empírica (notación de Hill): C₃₂H₄₁NO₂
• Número de CAS: 50679-08-8
• Peso molecular: 471.67
• Número MDL: MFCD00079622
• Código UNSPSC: 41116107
• NACRES: NA.24

Propiedades

• grado: pharmaceutical primary standard
• familia API: terfenadine
• Formulario: crystalline powder
• caducidad: limited shelf life, expiry date on the label
• fabricante / nombre comercial: BP
• aplicaciones: pharmaceutical; pharmaceutical small molecule
• Formato: neat
• temp. de almacenamiento: 2-8°C
• cadena SMILES: CC(C)(C)c1ccc(cc1)C(O)CCCN2CCC(CC2)C(O)(c3ccccc3)c4ccccc4
• InChI: 1S/C32H41NO2/c1-31(2,3)26-18-16-25(17-19-26)30(34)15-10-22-33-23-20-29(21-24-33)32(35,27-11-6-4-7-12-27)28-13-8-5-9-14-28/h4-9,11-14,16-19,29-30,34-35H,10,15,20-24H2,1-3H3
• Clave InChI: GUGOEEXESWIERI-UHFFFAOYSA-N
• Información sobre el gen: human ... HRH1(3269)

Descripción

Descripción general

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Aplicación

Terfenadine BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Acciones bioquímicas o fisiológicas

Non-sedating second generation H1 histamine receptor antagonist.

Non-sedating second generation H1 histamine receptor antagonist. Mainly metabolized by Cyp3A4, 5, 7. Inhibits CYP2C8.

Envase

Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

Otras notas

Sales restrictions may apply.